Emil Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-07-2024
- Paid Up Capital ₹ 0.27 M
as on 12-07-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 M
as on 12-07-2024
- Revenue -19.90%
(FY 2020)
- Profit 964.67%
(FY 2020)
- Ebitda 30.14%
(FY 2020)
- Net Worth 17.32%
(FY 2020)
- Total Assets 20.86%
(FY 2020)
About Emil Healthcare
The Corporate was formerly known as V S Medicare Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.27 M.
The company currently has active open charges totaling ₹4.50 M.
Rajendra Gole and Tushar Korday serve as directors at the Company.
- CIN/LLPIN
U33100MH1996PTC103490
- Company No.
103490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Emil Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Gole  | Director | 24-Oct-1996 | Current |
| Tushar Korday | Director | 24-Oct-1996 | Current |
Financial Performance and Corporate Structure Insights of Emil Healthcare.
Emil Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.9% decrease. The company also saw a substantial improvement in profitability, with a 964.67% increase in profit. The company's net worth Soared by an impressive increase of 17.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emil Healthcare?
In 2019, Emil Healthcare had a promoter holding of 47.16% and a public holding of 52.84%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medibios Laboratories LimitedActive 29 years 9 monthsRajendra Gole and Tushar Korday are mutual person
Emil Pharmaceutical Industries Pvt LtdActive 38 years 7 monthsRajendra Gole and Tushar Korday are mutual person
- Emil Holdings Private LimitedActive 29 years 4 months
Rajendra Gole and Tushar Korday are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Jan 2002 | ₹4.50 M | Open |
How Many Employees Work at Emil Healthcare?
Unlock and access historical data on people associated with Emil Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emil Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emil Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
